Severity
Moderate
FDA Food recall · Reported August 16, 2017
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.
Duy Drugs Inc. recalled Viva ben Femenine Supplement, Dietary Supplement 30 Softgels - a moderate-severity action.
Viva ben Femenine Supplement, Dietary Supplement 30 Softgels was recalled by Duy Drugs Inc. in August 16, 2017. Reason: Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplement…. Check the official notice for the remedy. Verify recall #F-3355-2017 with the FDA Food before acting.
The recall
Duy Drugs Inc. issued this moderate-severity FDA Food recall-Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplement….
Sourced from official FDA Food enforcement records. Verify recall #F-3355-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Food action (record #F-3355-2017) was formally reported on August 16, 2017, with the manufacturer initiating the action on July 21, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Duy Drugs Inc. is listed as the recalling firm, operating out of Doral, FL. Federal records list the affected scope as 1800 bottles.
The documented reason for this recall is: Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements. Distribution data in the federal record shows the product reached: Domestic distribution only.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 2,002 dietary supplements recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1800 bottles
Related Recalls
6
6 from same agency
Viva ben Femenine Supplement, Dietary Supplement 30 Softgels
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | F-3355-2017 |
| Date reported | August 16, 2017 |
| Date initiated | July 21, 2017 |
| Recalling firm | Duy Drugs Inc. |
| Firm location | Doral, FL |
| Affected scope | 1800 bottles |
| Distribution | Domestic distribution only. |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Herbal Creations USA · 2026-04-01
Winder Laboratories, LLC · 2026-03-25
Imu-Tek Animal Health, Incorporated · 2026-02-11
Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported August 16, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.